Write in a clean editor, then format for Frontiers in Oncology in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Oncology is a peer-reviewed journal published by Frontiers, covering Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Radiomics and Machine Learning in Medical Imaging. Over its lifetime it has published 37,688 papers, which have received 639,981 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Frontiers in Oncology. 2023;12(3):45–58.
Formats any DOI in Frontiers in Oncology style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis Radiomics and Machine Learning in Medical Imaging Cancer-related molecular mechanisms research Glioma Diagnosis and Treatment |
| ISSN | 2234-943X |
| Citation impact (2-yr) | 2.48 |
| h-index | 206 |
| i10-index | 16,277 |
| Article processing charge | $2,950 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Sun Yat-sen University |
| Journal website | www.frontiersin.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
The phosphatidylinositol-3-kinase (PI3K)/Akt and the mammalian target of rapamycin (mTOR) signaling pathways are two pathways crucial to many aspects of cell growth and survival, in physiological as well as in pathological conditions (e.g., cancer). Indeed, they are so interconnected that, in a certain sense, they could be regarded as a single, unique pathway. In this…
Melanoma, a skin cancer associated with high mortality rates, is highly radio- and chemotherapy resistant but can also be very immunogenic. These circumstances have led to a recent surge in research into therapies aiming to boost anti-tumor immune responses in cancer patients. Among these immunotherapies, neutralizing antibodies targeting the immune checkpoints T-lymphocyte-associated protein 4 (CTLA-4)…
During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of…
The phosphatidylinositol-3-kinase (PI3K)/Akt and the mammalian target of rapamycin (mTOR) signaling pathways are two pathways crucial to many aspects of cell growth and survival, in physiological as well as in pathological conditions (e.g., cancer). Indeed, they are so interconnected that, in a certain sense, they could be regarded as a single, unique pathway. In this…
Tumor cells must generate sufficient ATP and biosynthetic precursors in order to maintain cell proliferation requirements. Otto Warburg showed that tumor cells uptake high amounts of glucose producing large volumes of lactate even in the presence of oxygen, this process is known as "Warburg effect or aerobic glycolysis." As a consequence of such amounts of…
Frontiers in Antennas and Propagation
Frontiers in Arachnid Science
Frontiers in Bacteriology
Frontiers in Behavioral Neuroscience
Frontiers in Biomaterials Science
Frontiers in Built Environment
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Surgical and Experimental Pathology
